Posted by ABMN Staff on May 8th, 2024
Barclays restated their equal weight rating on shares of GSK (LON:GSK – Free Report) in a report released on Tuesday, Marketbeat Ratings reports. They currently have a GBX 1,725 ($21.67) price target on the stock.
GSK has been...
More of this article »